Serum antibodies to phosphatidylcholine in MS
Open Access
- 1 July 2020
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology Neuroimmunology & Neuroinflammation
Abstract
Objective To evaluate the value of serum immunoglobulin G (IgG) and immunoglobulin M (IgM) antibodies reactive with phosphatidylcholine (PC) and lactosylceramide (LC) as biomarkers in MS. Methods We developed an ultrasensitive ELISA technique to analyze serum IgG and IgM antibodies to LC and PC, which we used to analyze samples from 362 patients with MS, 10 patients with non-MS myelin diseases (Non-MSMYDs), 11 patients with nonmyelin neurologic diseases (Non-MYNDs), and 80 controls. MS serum samples included clinically isolated syndrome (CIS, n = 17), relapsing-remitting MS (RRMS, n = 62), secondary progressive MS (SPMS, n = 50), primary progressive MS (PPMS, n = 37), and benign MS (BENMS, n = 36). Results We detected higher levels of serum IgM antibodies to PC (IgM-PC) in MS than control samples; patients with CIS and RRMS showed higher IgM-PC levels than patients with SPMS, PPMS, and BENMS and controls. MS and control samples did not differ in serum levels of IgM antibodies reactive with LC, nor in IgG antibodies reactive with LC or PC. Conclusions Serum IgM-PC antibodies are elevated in patients with MS, particularly during the CIS and RRMS phases of the disease. Thus, serum IgM-PC is a candidate biomarker for early inflammatory stages of MS. Classification of evidence This study provides Class III evidence that serum antibodies to PC are elevated in patients with MS. The study is rated Class III because of the case control design and the risk of spectrum bias: antibody levels in patients with MS were compared with healthy controls.Keywords
This publication has 44 references indexed in Scilit:
- Lipid arrays identify myelin-derived lipids and lipid complexes as prominent targets for oligoclonal band antibodies in multiple sclerosisJournal of Neuroimmunology, 2011
- Accuracy of diagnostic tests in multiple sclerosis - a systematic reviewActa Neurologica Scandinavica, 2010
- Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAENature Immunology, 2009
- CSF oligoclonal band patterns reveal disease heterogeneity in multiple sclerosisJournal of Neuroimmunology, 2009
- CTP:Phosphocholine Cytidylyltransferase α Is Required for B-cell Proliferation and Class Switch RecombinationOnline Journal of Public Health Informatics, 2009
- Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosisProceedings of the National Academy of Sciences of the United States of America, 2008
- Induction of IgG3 to LPS via Toll-Like Receptor 4 Co-StimulationPLOS ONE, 2008
- A model for the comprehensive investigation of a chronic autoimmune disease: The multiple sclerosis CLIMB studyAutoimmunity Reviews, 2006
- Implications for Induction of Autoimmunity via Activation of B-1 Cells byHelicobacter pyloriUreaseInfection and Immunity, 2006
- T-Independent Immune Response: New Aspects of B Cell BiologyScience, 2000